Solving data to enable precision therapy for all Follow us on LinkedIn for the latest news: https://teapaw.org/t.co/yfuxXvuKPX
Cambrigde, UK
Joined August 2022
- Tweets81
- Following74
- Followers10
- Likes1
As world’s cancer research community prepares to gather at the ASCO Annual Meeting, catch up with our recent studies presented earlier this year at AACR:
bit.ly/concr-event-aacr2023
#precisiononcology
#MachineLearning
#techbio
#FromCosmologyToOncology
95
Listen to our CEO Matt Foster discuss origins of Concr and how we work with partners to improve drug development to realise the promise of #PrecisionOncology in this episode of AI for Pharma Growth:
bit.ly/concr-intro-8
#AI #MachineLearning #TechBio #FromCosmologyToOncology
55
#LSXWorld Congress in only 2 days away!
You’re invited to our showcase on 3rd May at 14.30 at the newly-established techbio stage, to find out more about our current work and plans for the future.
bit.ly/concr-event-10
#techbio #precisiononcology #fromcosmologytooncology
1
70
To access the story and learn more about VISION:
bit.ly/concr-intro-7
#SaMD
#Genomics
#ClinicalTrials
#BreastCancer
#PrecisionOncology
#FromCosmologyToOncology
34
Biomarkers hold the key to unlocking the links between intricate biological processes and clinical outcomes. For biomarkers to pave the way for reliable and accessible #PersonalisedMedicine, particularly in #cancer, they must be accurate, informative and cost-effective.
1
27
In this piece, they explore how #biomarkers have already revolutionised the current clinical landscape, and what more needs to be done, in order to match more #cancer patients with safer, more effective and affordable therapies.
1
20
To read the article:
bit.ly/concr-explainer-7
#TechBio
#Biomarkers
#CancerResearch
#PrecisionOncology
#FromCosmologyToOncology
18
If you're at #AACR23 today, then make sure to listen to Dr Aidan Kubeyev present on the results of the latest application of Concr’s prognostic #MachineLearning models on early #BreastCancer.
1
40
Join Dr Matthew Griffiths and Dr Uzma Asghar in the poster hall (Section 33, Board Numbers 7 and 12) from 1:30 PM to learn about how Concr technology can differentiate tumours from other cell types from H&E slides, and identify tissue of origin from somatic mutation features.
1
17
For more information about the Concr presentation and posters:
bit.ly/concr-event-7
#TechBio #Cancer
#MachineLearning
#TranslationalOncology
#FromCosmologyToOncology
38
Concr will be attending the 9th #LSXWorld Congress in London next month.
Our Head of Strategy, Dr Irina Babina, will join the representatives of leading #biotech, #medtech and #healthtech companies to discuss the future of healthcare and life sciences innovation.
1
27
Find us at the TechBio Showcase on May 3rd at 2:30 PM or get in touch to book a 1:1 today!
To find out more about Concr at LSX World Congress 2023:
bit.ly/concr-event-10
#TechBio
#LSXWorld
#PrecisionMedicine
#FromCosmologyToOncology
24
Only three days left before #AACR23!
With two posters and an oral presentation, there will be much to talk about!
Come find us presenting on Tuesday 18th, or get in touch now to lock in a meeting with the Concr delegation:
lnkd.in/gzVkfJkt
1
36
For more information about Concr at #AACR23: lnkd.in/gtgnpWh5
#TechBio #Cancer
#MachineLearning
#TranslationalOncology
#FromCosmologyToOncology
What do ultramassive #BlackHoles and #Cancer have in common?
They are “elusive, and their origins are unclear”.
Additionally, both are studied by our Durham University collaborator, @JwNightingale22, who applied a technique called #GravitationalLensing to the discovery.
A team of #astronomers lead by @JwNightingale22 from @DurhamPhysics has discovered one of the biggest #blackholes ever found using light-bending gravity.
Find out more about this research, published today by @RoyalAstroSoc here 👉 fal.cn/3wXWd
#DUresearch
The same statistical methodologies are at the heart of Concr’s algorithms aimed at unearthing #biomarkers of response to cancer treatments.
To learn more about how Concr utilises this approach to make sense of disparate #oncology data:
bit.ly/concr-exp-6
#TechBio
7